TrialLipids2016

Docosahexaenoic Acid Attenuates Cardiovascular Risk Factors via a Decline in Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Plasma Levels.

Celia Rodríguez-Pérez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.